2 búsqueda de la palabra clave 'thrombotic microangiopathies'

Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli in a renal transplant recipient case report / John Fredy Nieto Ríos ; Mónica Zuluaga Quintero ; Arbey Aristizabal Álzate ; Gustavo Adolfo Zuluaga Valencia    

Público ISBD Título : Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli in a renal transplant recipient case report Tipo de documento : documento electrónico Autores : John Fredy Nieto Ríos, ; Mónica Zuluaga Quintero, ; Arbey Aristizabal Álzate, ; Gustavo Adolfo Zuluaga Valencia, Fecha de publicación : 2021 Títulos uniformes : Brazilian Journal of Nephrology Idioma : Inglés (eng) Palabras clave : Thrombotic Microangiopathies  Hemolytic-Uremic Syndrome  Shiga Toxin  Kidney Transplantation  ADAMTS13 Protein  Alternative Complement Pathway Resumen : Thrombotic microangiopathies are disorders characterized by nonimmune microangiopathic hemolytic anemia, thrombocytopenia, and multi-systemic failure. They are classified as thrombotic thrombocytopenic purpura, atypical hemolytic-uremic syndrome, and typical hemolytic uremic syndrome. The latter is associated with intestinal infections by Shiga toxin-producing bacteria. Typical hemolytic uremic syndrome in adults is an extremely rare condition, characterized by high morbidity and mortality. It has been seldom described in solid organ transplant recipients. Here is presented the case of a kidney transplant recipient who had typical hemolytic uremic syndrome with multisystem commitment, refractory to management and with a fatal outcome. Mención de responsabilidad : John Fredy Nieto-Rios, Monica Zuluaga-Quintero, Julio Cesar Valencia-Maturana, Diana Carolina Bello-Marquez, Arbey Aristizabal-Alzate, Gustavo Adolfo Zuluaga-Valencia, Lina Maria Serna-Higuita, Luis Fernando Arias Referencia : J Bras Nefrol. Oct-Dec 2021;43(4):591-596. DOI (Digital Object Identifier) : 10.1590/2175-8239-jbn-2020-0048 PMID : 33179720 Derechos de uso : CC BY En línea : https://bjnephrology.org/en/article/hemolytic-uremic-syndrome-caused-by-shiga-to [...] Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=5737 Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli in a renal transplant recipient case report [documento electrónico] / John Fredy Nieto Ríos, ; Mónica Zuluaga Quintero, ; Arbey Aristizabal Álzate, ; Gustavo Adolfo Zuluaga Valencia,  . - 2021. Obra : Brazilian Journal of Nephrology Idioma : Inglés (eng) Palabras clave : Thrombotic Microangiopathies  Hemolytic-Uremic Syndrome  Shiga Toxin  Kidney Transplantation  ADAMTS13 Protein  Alternative Complement Pathway Resumen : Thrombotic microangiopathies are disorders characterized by nonimmune microangiopathic hemolytic anemia, thrombocytopenia, and multi-systemic failure. They are classified as thrombotic thrombocytopenic purpura, atypical hemolytic-uremic syndrome, and typical hemolytic uremic syndrome. The latter is associated with intestinal infections by Shiga toxin-producing bacteria. Typical hemolytic uremic syndrome in adults is an extremely rare condition, characterized by high morbidity and mortality. It has been seldom described in solid organ transplant recipients. Here is presented the case of a kidney transplant recipient who had typical hemolytic uremic syndrome with multisystem commitment, refractory to management and with a fatal outcome. Mención de responsabilidad : John Fredy Nieto-Rios, Monica Zuluaga-Quintero, Julio Cesar Valencia-Maturana, Diana Carolina Bello-Marquez, Arbey Aristizabal-Alzate, Gustavo Adolfo Zuluaga-Valencia, Lina Maria Serna-Higuita, Luis Fernando Arias Referencia : J Bras Nefrol. Oct-Dec 2021;43(4):591-596. DOI (Digital Object Identifier) : 10.1590/2175-8239-jbn-2020-0048 PMID : 33179720 Derechos de uso : CC BY En línea : https://bjnephrology.org/en/article/hemolytic-uremic-syndrome-caused-by-shiga-to [...] Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=5737

Reserva

Reservar este documento

Ejemplares(1)

Código de barras	Número de Ubicación	Tipo de medio	Ubicación	Sección	Estado
DD001676	AC-2020-147	Archivo digital	Producción Científica	Artículos científicos	Disponible

Documentos electrónicos

2020-147 Adobe Acrobat PDF

Hemolytic uremic syndrome due to gemcitabine in a young woman with cholangiocarcinoma / John Fredy Nieto Ríos ; Catalina Ocampo Kohn ; Cristian Iván García Rincón ; Kenny Mauricio Gálvez Cárdenas ; Arbey Aristizabal Álzate ; Gustavo Adolfo Zuluaga Valencia    

Público ISBD Título : Hemolytic uremic syndrome due to gemcitabine in a young woman with cholangiocarcinoma Tipo de documento : documento electrónico Autores : John Fredy Nieto Ríos, ; Catalina Ocampo Kohn, ; Cristian Iván García Rincón, ; Kenny Mauricio Gálvez Cárdenas, ; Arbey Aristizabal Álzate, ; Gustavo Adolfo Zuluaga Valencia, Fecha de publicación : 2016 Títulos uniformes : Brazilian Journal of Nephrology Idioma : Inglés (eng) Palabras clave : Acute kidney injury  cholangiocarcinoma  hemolyticuremic syndrome  thrombotic microangiopathies Resumen : Gemcitabine is a medication used to treat various types of malignant neoplasms. Its association with hemolytic uremic syndrome (HUS) has been described in few cases, although these cases have resulted in mortality rates of at least 50%. We report on the case of a 25-year-old patient with cholangiocarcinoma in remission who developed microangiopathic hemolytic anemia with acute anuric renal failure after receiving 5 cycles of gemcitabine chemotherapy; this condition was consistent with HUS caused by the side effects of this drug. The administration of gemcitabine was stopped, and hemodialysis, blood transfusions, plasma exchanges, steroids, doxycycline, and rituximab were used to treat the patient. A favorable outcome was achieved; in particular, hemolysis was controlled, and renal function was completely recovered. Mención de responsabilidad : John Fredy Nieto-Ríos, Mónica Zuluaga-Quintero, Lina Maria Serna Higuita, Cristian Ivan García Rincón, Kenny Mauricio Galvez-Cárdenas, Catalina Ocampo-Kohn, Arbey Aristizabal-Alzate, Adriana Alejandra Florez-Vargas, Gustavo Adolfo Zuluaga-Valencia Referencia : J Bras Nefrol. 2016 Jun;38(2):255-9. DOI (Digital Object Identifier) : 10.5935/0101-2800.20160035 PMID : 27438981 Derechos de uso : CC BY En línea : http://bjn.org.br/details/1860/en-US/hemolytic-uremic-syndrome-due-to-gemcitabin [...] Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=3965 Hemolytic uremic syndrome due to gemcitabine in a young woman with cholangiocarcinoma [documento electrónico] / John Fredy Nieto Ríos, ; Catalina Ocampo Kohn, ; Cristian Iván García Rincón, ; Kenny Mauricio Gálvez Cárdenas, ; Arbey Aristizabal Álzate, ; Gustavo Adolfo Zuluaga Valencia,  . - 2016. Obra : Brazilian Journal of Nephrology Idioma : Inglés (eng) Palabras clave : Acute kidney injury  cholangiocarcinoma  hemolyticuremic syndrome  thrombotic microangiopathies Resumen : Gemcitabine is a medication used to treat various types of malignant neoplasms. Its association with hemolytic uremic syndrome (HUS) has been described in few cases, although these cases have resulted in mortality rates of at least 50%. We report on the case of a 25-year-old patient with cholangiocarcinoma in remission who developed microangiopathic hemolytic anemia with acute anuric renal failure after receiving 5 cycles of gemcitabine chemotherapy; this condition was consistent with HUS caused by the side effects of this drug. The administration of gemcitabine was stopped, and hemodialysis, blood transfusions, plasma exchanges, steroids, doxycycline, and rituximab were used to treat the patient. A favorable outcome was achieved; in particular, hemolysis was controlled, and renal function was completely recovered. Mención de responsabilidad : John Fredy Nieto-Ríos, Mónica Zuluaga-Quintero, Lina Maria Serna Higuita, Cristian Ivan García Rincón, Kenny Mauricio Galvez-Cárdenas, Catalina Ocampo-Kohn, Arbey Aristizabal-Alzate, Adriana Alejandra Florez-Vargas, Gustavo Adolfo Zuluaga-Valencia Referencia : J Bras Nefrol. 2016 Jun;38(2):255-9. DOI (Digital Object Identifier) : 10.5935/0101-2800.20160035 PMID : 27438981 Derechos de uso : CC BY En línea : http://bjn.org.br/details/1860/en-US/hemolytic-uremic-syndrome-due-to-gemcitabin [...] Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=3965

Reserva

Reservar este documento

Ejemplares(1)

Código de barras	Número de Ubicación	Tipo de medio	Ubicación	Sección	Estado
DD000553	AC-2016-028	Archivo digital	Producción Científica	Artículos científicos	Disponible

Documentos electrónicos

2016-028.pdf Adobe Acrobat PDF